Our new paper focuses on the conversation around novel cell-based therapies for COVID-19 patients. Within this paper we explore the efficacy and safety of these coronavirus treatments and discuss the importance of tightly-regulated “compassionate use” and adequate evidence regarding these cell-based approaches.
New paper in Nature Communications
Our new paper in Nature Communications describes the genetic program of in vivo lung primordial progenitors and use of computational similarity analysis to improve lung directed differentiation of pluripotent stem cells. A great collaborative effort with the groups of Darrell Kotton, Pankaj Mehta, Eric Kolaczyk, Bob Varelas, Dave Frank, and Ed Morrisey.
New Publication in Lancet Respiratory Medicine
Our comment on the co-opting of the federal database ClinicalTrials.gov by businesses offering unproven and unlicensed cell-based interventions is published in the August 2018 issue of Lancet Respiratory Medicine.
Many thanks to our co-authors, Darcy Wagner, Leigh Turner, Angela Panoskaltsis-Mortari, and Dan Weiss.
New Article in Cytotherapy
Our new paper on marketing of unproven stem cell interventions and the role of medical societies in patient advocacy and education is published in Cytotherapy.
This work was in collaboration with Daniel J. Weiss, Professor of Medicine, University of Vermont College of Medicine; Leigh Turner, Associate Professor, Center for Bioethics, University of Minnesota; and Aaron D. Levine, Associate Professor, School of Public Policy, Georgia Institute of Technology.
Lab Members Next Steps
Congratulations to Keri Dame and Matt Lawton on their next career steps! Keri is now an ORISE Fellow in the Division of Applied Regulatory Science of the FDA and Matt is a graduate student at Boston University’s Program in Biomedical Sciences.
Keri Dame’s Thesis Defense
July 7th 2017
Congratulations to Keri Dame for the succesfull defense of her thesis, making her the first PhD graduate of the Ikonomou lab!
Stem Cell Working Group writes patient-centered piece on unproven stem cell therapies
April 1st, 2017
Dr. Ikonomou and other members of the American Thoracic Society Stem Cell Working Group wrote an AJRCCM patient-centric Public Health information piece on unproven “stem cell” interventions for lung disease. Thanks to the ATS, the COPD Foundation, the Asian Pacific Society of Respirology, the Pulmonary Hypertension Association of Canada and the Malaysian Thoracic Society for featuring this piece on their websites.
CReM PIs Laertis Ikonomou and Andrew Wilson publish chapter on lung regeneration
March 31st, 2017
Check out the “Development and Bioengineering of Lung Regeneration” chapter written by KIWi group’s PIs Andrew Wilson and Laertis Ikonomou. It is part of the “Organ Regeneration Based on Developmental Biology” book (Springer Singapore).
National Herald features interview with Dr. Ikonomou
February 11th, 2017
The National Herald, a Greek-American publication, features an interview with Dr. Ikonomou about the latest work published by our lab on efficient thyroid progenitor derivation from pluripotent stem cells.